Search alternatives:
significantly less » significantly lower (Expand Search), significantly reduce (Expand Search), significantly better (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
Showing 1,841 - 1,860 results of 2,669 for search '(( significantly ((linear decrease) OR (largest decrease)) ) OR ( significantly less decrease ))', query time: 0.59s Refine Results
  1. 1841
    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 4_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  2. 1842
    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 1_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  3. 1843
    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 5_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  4. 1844
    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 2_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  5. 1845
    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel associations between genomic alterations, TMB, and PD-L1.xlsx

    Table 3_Genomic profiling of NSCLC tumors with the TruSight oncology 500 assay provides broad coverage of clinically actionable genomic alterations and detection of known and novel... by Zachary D. Wallen (19986522)

    Published 2024
    “…</p>Discussion<p>This study is the largest clinical study to date utilizing the TSO 500. …”
    Save to List
    Saved in:
  6. 1846
    Image 9_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 9_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  7. 1847
    Table 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.xlsx

    Table 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.xlsx by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  8. 1848
    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 8_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  9. 1849
    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 5_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  10. 1850
    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 2_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  11. 1851
    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 3_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  12. 1852
    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 4_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  13. 1853
    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 11_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  14. 1854
    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 1_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  15. 1855
    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 10_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  16. 1856
    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 7_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  17. 1857
    Image 6_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg

    Image 6_Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma.jpeg by Xiaqin Zhang (10211396)

    Published 2025
    “…Richness was significantly decreased from pre-treat to post-treat.…”
    Save to List
    Saved in:
  18. 1858
    Table 1_Early detection of retinal and choroidal microvascular impairments in diabetic patients with myopia.docx

    Table 1_Early detection of retinal and choroidal microvascular impairments in diabetic patients with myopia.docx by Yufei Wu (3625967)

    Published 2025
    “…The AI-driven analysis revealed that decreased CVI and CT were significantly associated with age and spherical equivalent (SE), highlighting the utility of automated algorithms in identifying early microvascular impairments.…”
    Save to List
    Saved in:
  19. 1859
    (A) Predicted probabilities of snails at or above the water line across different fish species chemical cues.

    (A) Predicted probabilities of snails at or above the water line across different fish species chemical cues. by Alexandra Sack (4805601)

    Published 2025
    “…Snails exposed to <i>C. gariepinus</i> chemical cues decreased their use of the vegetation over time as compared to snails in the control tanks, but the proportion of snails in the vegetation through time otherwise did not significantly differ from the controls for any other fish species. …”
    Save to List
    Saved in:
  20. 1860
    Image 1_Comparative analysis of gut microbiota in metabolic syndrome and obese children from Southeastern China.jpeg

    Image 1_Comparative analysis of gut microbiota in metabolic syndrome and obese children from Southeastern China.jpeg by Jingjing Wang (140791)

    Published 2024
    “…At the class and genus levels, we found that the relative abundance of c_Gammaproteobacteria increased with weight, whereas c_Bacteroidia and g_Bacteroides decreased. Notably, g_Faecalibacterium was significantly less abundant in the MS group compared to the other cohorts. …”
    Save to List
    Saved in:

Search Tools: